返回 
加入收藏
以药师为主导的全程化用药管理模式在风湿免疫性疾病中的实践研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 以药师为主导的全程化用药管理模式在风湿免疫性疾病中的实践研究 |
| TITLE： | Practice and research on the whole course medication management mode led by pharmacists in rheumatic immune diseases |
| 摘要： | 目的 评价以药师为主导的全程化用药管理模式在风湿免疫性疾病中的应用效果。方法选择2018－2020年在武汉市第一医院风湿免疫科使用他克莫司或环孢素治疗的122例风湿免疫性疾病患者为研究对象。其中，对照组44例，采用传统监管模式；观察组78例，采用以药师为主导的全程化用药管理模式，即由个体化药师和专科临床药师协同与主导，不仅参与药物治疗全过程，还参与治疗药物监测（TDM）全过程，在对照组基础上强化了医药护三方分工协作，并从住院延伸到出院对门诊和住院患者实施同质化监管。比较两组患者的用药日剂量、血药浓度达标率、问题标本（标本以例次计）发生率、平均住院日、出院6个月再入院率、用药依从性评分、患者满意率。结果对照组患者实施TDM53例次，其中他克莫司监测18例次、环孢素监测35例次；观察组患者实施TDM123例次，其中他克莫司监测55例次、环孢素监测68例次。观察组患者他克莫司日剂量、环孢素日剂量、环孢素血药浓度达标率、问题标本发生率、出院6个月再入院率、用药依从性评分、患者满意率均显著优于对照组（P＜0.05）。结论以药师为主导对风湿免疫性疾病患者实施全程化、同质化用药管理并提供精准用药指导，可以有效提高药物治疗效果，提升药学服务质量。 |
| ABSTRACT： | OBJECT IVE To evaluate the application effect of the whole cour se medication management mode led by pharmacists in rheumatic immune diseases. METHODS A total of 122 patients treated with tacrolimus or cyclosporine in the department of rheumatology and immunology of Wuhan No. 1 Hospital from 2018 to 2020 were selected as the study subjects. Among them ，44 cases in the control group were under the traditional supervision mode ；78 patients in the observation group adopted the whole course medication management mode led by pharmacists ，that was ，individual pharmacists and specialist clinical pharmacists cooperated and led ，and not only participated in the whole process of drug treatment but also involved in the whole process of therapeutic drug monitoring （TDM）. On the basis of the control group ，the division of labor and cooperation among medical，pharmaceutical and nursing parties were strengthened ，and the homogeneous supervision was carried out for the outpatients and inpatients from admission to discharge . The daily dose of medication ，the rate of reaching the standard of blood drug concentration ，the incidence of problematic samples （the sample was calculated by the number of times ），the average hospitalization days ，the re-admission rate within 6 months after discharge ，the medication compliance score and the patient ’s satisfaction rate were compared between the two groups. RESULTS In the control group ，53 times of TDM were performed ， including 18 times of tacrolimus monitoring and 35 times of cyclosporine monitoring ；in the observation group ，123 timesof TDM were performed ，including 55 times of tacrolimus monitoring and 68 times of cyclosporine monitoring. The daily dose of tacrolimus ，the daily dose of cyclosporine ，the rate of reaching the standard of cyclosporine blood drugconcentration，the inc idence of problematic samples ，the rate of re-admission within 6 months after discharge ， the medication compliance score and the patient ’s satisfaction rate in the observation group were significantly better than those in the control group （P＜0.05）. CONCLUSIONS It can effectively improve the effect of the quality of pharmaceutical care to implement whole course and homogeneous medication management led by pharmacists and provide precise drug guidance for patients with rheumatic and immune diseases. |
| 期刊： | 2022年第33卷第17期 |
| 作者： | 刘剑敏，林奕凯，黄鹤归，黄烨，范秋玉，杨惠琴，张韶辉 |
| AUTHORS： | LIU Jianmin ，LIN Yikai，HUANG Hegui，HUANG Ye，FAN Qiuyu，YANG Huiqin ，ZHANG Shaohui |
| 关键字： | 个体化药师；风湿免疫性疾病；全程化用药管理；专科临床药师；药学服务 |
| KEYWORDS： | individual pharmacist；rheumatic immune disease ；whole course medication management ；specialist clinical |
| 阅读数： | 298 次 |
| 本月下载数： | 12 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
